An interventional study of low sodium diet in Oligohydramnios, sponsored by Wolfson Medical Center. Status unknown at 1 site in Israel. Per ClinicalTrials.gov, last updated 2019-01-25.
Sponsored by Wolfson Medical Center · Not applicable, Interventional, and Treatment
The investigators want to examine whether low salt diet can increase the amniotic fluid index in patients diagnosed with oligohydramnios and assigned for conservative management. A randomized controlled trial
Few studies have addressed the changes in maternal diet as affecting the composition and amount of amniotic fluid.
Some articles have shown an increase in amniotic fluid volume as a result of maternal hydration during pregnancy through intravenous fluid infusions and oral fluid intake, the increase was evident in women with amniotic fluid and women with normal amniotic fluid volume. In a mechanism similar to that of liquid hydration, a low-salt diet may lead to an increase in the volume of amniotic fluid.
The investigators would like to examine whether a low-salt diet in women with amniotic fluid is able to significantly increase the amount of amniotic fluid compared with a regular diet.
25 studies on the registry are indexed under Oligohydramnios; 5 are open to participants now.
This study's planned enrollment of 80 is below the median of 91 across 16 interventional studies indexed under Oligohydramnios.
Browse Oligohydramnios studies →Wolfson Medical Center is the lead sponsor of 118 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
women diagnosed with oligohydramnios designated for conservative management applying a low-salt diet.
Other: low sodium diet
women diagnosed with oligohydramnios designated for conservative management applying a regular diet.
included in the diet mostly low sodium food. avoid tinned or smoked, food. avoid adding salt to the food.
Also known as: low salt diet
amniotic fluid volume, assessed by ultrasound
amniotic fluid volume after two weeks
Time frame: two weeks
gestational age at birth
Time frame: up to 18 weeks (until delivery)
induction of labor
The percentage of pregnant women who underwent birth induction
Time frame: up to 18 weeks (until delivery)
labor type
Cesarean section, vaginal birth or vaginal birth
Time frame: up to 18 weeks (until delivery)
Pregnancy and childbirth complications
obstetrics complications and neonatal complications
Time frame: up to 18 weeks (until delivery)
Plan to share: No
Start is estimated for Feb 2019; primary completion for Dec 2019, 10 months later.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.